Table 5.
Examples of carbon or polymer-modified lipid nanoparticles
| Photoresponsive material | Nanocomposition | Wavelength (nm) | Application | Endpoint | References |
|---|---|---|---|---|---|
| Single-walled carbon nanotubes and multi-walled carbon nanotubes | Peptide Lipid:Sucrose laurate = 1:1 (w/w) | 808 |
PTT On-demand drug release |
In vivo study | Zhao et al. (2021) |
| Graphene oxide, graphene oxide-conjugated poly(L-lysine) |
DPPC:Brij® S20: DOTAP:Cholesterol = 66:4:20:10 (m/m) |
808 |
Chemo-PTT On-demand drug release |
In vitro study | Hashemi et al. (2018) |
| Malachite green copolymer | Egg yolk lecithin | 625 | On-demand drug release | Proof-of-concept | Uda et al. (2016) |
| Polydopamine | DPPC:DPPG:DSPE-malPEG2000 = 7:3:0.1 (m/m) | 808 | PTT | In vivo study | Yang et al. (2020) |
GO graphene oxide, GO-PLL graphene oxide-conjugated poly(l-lysine); Brij® S20, polyoxyethylene (20) stearyl ether, DOTAP 1,2-dioleoyl-3-trimethylammonium-propane, DPPC 1,2-dipalmitoyl-sn-glycero-3-phospho-choline, DPPG 1,2-dipalmitoyl-sn-glycero-3-phosphorylglycerol, DSPE-malPEG2000 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethylene glycol)-2000], PTT photothermal therapy